Clarius Group LLC Has $3.06 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Clarius Group LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 17.1% during the 1st quarter, HoldingsChannel reports. The fund owned 5,845 shares of the healthcare conglomerate’s stock after selling 1,208 shares during the quarter. Clarius Group LLC’s holdings in UnitedHealth Group were worth $3,061,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Norges Bank acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $6,375,744,000. GAMMA Investing LLC grew its holdings in shares of UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter worth $1,914,740,000. Amundi lifted its position in UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate’s stock worth $3,183,132,000 after purchasing an additional 2,991,470 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in UnitedHealth Group by 36.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock valued at $4,346,712,000 after buying an additional 2,301,010 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.5%

Shares of NYSE UNH opened at $309.14 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The stock has a market capitalization of $280.43 billion, a P/E ratio of 12.95, a P/E/G ratio of 1.44 and a beta of 0.44. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85. The company has a 50-day moving average price of $376.32 and a 200-day moving average price of $469.08.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period last year, the company earned $6.91 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be given a dividend of $2.21 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 37.02%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Stephen J. Hemsley purchased 86,700 shares of the firm’s stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now owns 679,493 shares of the company’s stock, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The stock was acquired at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders bought 109,408 shares of company stock worth $31,607,768. Insiders own 0.28% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on UNH. Wells Fargo & Company reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Friday, June 6th. Mizuho decreased their price target on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating on the stock in a research note on Friday, May 16th. Barclays reduced their price objective on UnitedHealth Group to $350.00 and set an “overweight” rating on the stock in a research note on Monday, June 2nd. Deutsche Bank Aktiengesellschaft dropped their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a report on Wednesday, May 14th. Finally, Piper Sandler lowered their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research report on Tuesday, June 3rd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $426.52.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.